Targeting HSP90 in Ovarian Cancers With Multiple Receptor Tyrosine Kinase Coactivation

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-10-125
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Multiple Roles for the Receptor Tyrosine Kinase Axl in Tumor Formation

Cancer Research
Cancer ResearchOncology
2005English

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers

Clinical Cancer Research
Cancer ResearchOncology
2004English

Diverse Distribution of Tyrosine Receptor Kinase B Isoforms in Rat Multiple Tissues

Journal of Veterinary Medical Science
Veterinary
2017English

A High-Content EMT Screen Identifies Multiple Receptor Tyrosine Kinase Inhibitors With Activity on TGFβ Receptor

Oncotarget
Oncology
2016English

Targeting Tumour Microenvironment by Tyrosine Kinase Inhibitor

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

Receptor Tyrosine Kinase (RTK); VEGF-A

Science-Business eXchange
2014English

Receptor Tyrosine Kinase–like Orphan Receptor 1 (ROR1)

Science-Business eXchange
2012English

AXL Receptor Tyrosine Kinase (AXL; UFO)

Science-Business eXchange
2014English

RYK, a Receptor Tyrosine Kinase-Related Molecule With Unusual Kinase Domain Motifs.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy